Quotes

Back To Menu

Corporate Actions Calendar

Corporate actions indicate company's financial performance and can signal about its future prospects. Have a sneak peak at all the Corporate actions scheduled in the near future.

MONTHLY

Corporate Actions Calender

September 2015

Tue Wed Thur Fri Sat Sun Mon
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

33 Corporate Actions for Jul 27 2024

26 Jul 24 | 3:59 PM

1 - 5 of 34

  • IFB Industries
    IFB Industries

    Event Type: Result

    • Latest Trading Price

      1,842.55

      104.306.00%

    • Details

      IFB INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of IFB Industries Limited will be held on Saturday 27th July 2024 to consider and take on record the Un Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2024 beside other matters.

      IFB INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of IFB Industries Limited will be held on Saturday 27th July 2024 to consider and take on record the Un Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2024 beside other matters.
    Invest
  • Dr Reddy's Labs
    Dr Reddy's Labs

    Event Type: Result

    • Latest Trading Price

      6,892.15

      37.950.55%

    • Details

      DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ending on June 30 2024

      DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ending on June 30 2024
    Invest
  • Finolex Inds.
    Finolex Inds.

    Event Type: Result

    • Latest Trading Price

      317.60

      0.100.03%

    • Details

      FINOLEX INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30th June 2024

      FINOLEX INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve Un-audited Financial Results for the quarter ended 30th June 2024
    Invest
  • BWL
    BWL

    Event Type: Result

    • Latest Trading Price

      0.00

      0.000.00%

    • Details

      BWL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve UNAUDITED FINANCIAL RESULT FOR QUATER ENDED JUNE 2024

      BWL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve UNAUDITED FINANCIAL RESULT FOR QUATER ENDED JUNE 2024
    Invest
  • Anant Raj
    Anant Raj

    Event Type: Result

    • Latest Trading Price

      536.35

      21.504.18%

    • Details

      Anant Raj Limited-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ending June 30 2024.

      Anant Raj Limited-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve and take on record the Unaudited Financial Results (Standalone and Consolidated) for the quarter ending June 30 2024.
    Invest
View All